Kyoto Drug Discovery and Development
Osaka
About Kyoto Drug Discovery and Development
KDDD develop an innovative agent effective for various INCURABLE or INTRACTABLE eye diseases, especially CRAO, Retinal Pigmentosa, AMD and Glaucoma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.9M
- Funding stage: Seed
- Last round: Seed (Feb 2018)
- Website: kyoto-drug.com
- Phone: +81 06-7777-1003
Industries & Categories
Health Care, Manufacturing, Medical Device, Pharmaceutical, Product Research
Canonical: https://fsome.com/organization/kyoto-drug-discovery-and-development-86705 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.